Biometabolic Research Unit
- Establishment and operation of advanced analytical infrastructure based on NMR and mass spectrometry for the analysis of various biological samples
- Development of untargeted and targeted metabolomics and lipidomics analysis methods, and conduct of collaborative research with domestic and international research institutes by applying them to various fields of life science and medicine
Research Content
Integrated metabolomics analysis platform
Metabolomics data analysis technology
Research Infrastructure
Establishment of an integrated metabolomics analysis platform based on NMR/MS instruments for biological samples and research on metabolic mechanisms
- Establishment of an integrated metabolomics analysis platform based on NMR/MS, and conduct of research using this platform to analyze metabolite changes according to disease onset and progression, drug response, and environmental factors, and to interpret molecular mechanisms at the metabolic pathway level
- Integrated interpretation of molecular networks at the biological system level through integrative analysis with other omics data such as proteomics, genomics, and transcriptomics
- Conduct of research on elucidating the mechanisms of onset of intractable and chronic diseases and developing therapeutic strategies by applying new metabolic control technologies
- Conduct of research on discovering metabolite biomarkers for disease prediction, diagnosis, and treatment response evaluation using metabolomics big data analysis technologies for large-scale clinical samples
Conduct of research on elucidating the mechanisms of onset of intractable and chronic diseases and developing therapeutic strategies using new metabolic control technologies
Recent research achievement of the Biometabolic Research Unit (2025) : Research on the discovery of metabolomics-based early diagnostic markers for hepatic steatosis associated with gestational diabetes
Published in Cardiovascular Diabetology, IF=10.6, top 5.21% in JCR, March 2025
